Get the Stockscreener App
1.56
17.29%
0.23
After Hours:
1.56
Tenaya Therapeutics Inc stock is traded at $1.56, with a volume of 5.27M.
It is up +17.29% in the last 24 hours and up +38.05% over the past month.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
See More
Previous Close:
$1.33
Open:
$1.33
24h Volume:
5.27M
Relative Volume:
1.68
Market Cap:
$254.24M
Revenue:
-
Net Income/Loss:
$-111.13M
P/E Ratio:
-1.1818
EPS:
-1.32
Net Cash Flow:
$-91.53M
1W Performance:
+27.87%
1M Performance:
+38.05%
6M Performance:
+122.86%
1Y Performance:
-20.81%
1-Day Range:
$1.32
$1.56
1-Week Range:
$1.24
$1.56
52-Week Range:
$0.36
$4.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Name
Tenaya Therapeutics Inc
Sector
Industry
Phone
415-865-2066
Address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Compare TNYA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
1.56 | 216.76M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-24 | Initiated | William Blair | Outperform |
| Nov-30-23 | Initiated | Leerink Partners | Outperform |
| Jun-15-22 | Initiated | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Stock (TNYA) Latest News
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $6.25 Average Target Price from Brokerages - MarketBeat
Can Tenaya Therapeutics Inc generate free cash flowPortfolio Return Report & Fast Moving Market Watchlists - خودرو بانک
Tenaya Therapeutics, Inc.(NasdaqGS: TNYA) dropped from S&P Global BMI Index - MarketScreener
Forecast Cut: Does Tenaya Therapeutics Inc have a competitive edgeWeekly Trend Report & Long-Term Growth Plans - خودرو بانک
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
Tenaya Therapeutics Grants Stock Options to New Employees as Part of Employment Offer - Quiver Quantitative
202,000 Shares at $1.20: Tenaya Therapeutics Grants Inducement Stock Options to New Employees - Stock Titan
Signal Recap: Can Tenaya Therapeutics Inc. reach all time highs this yearTrade Risk Summary & Weekly High Momentum Picks - خودرو بانک
Quarterly Risk: Is Westrock Coffee Company a stock for growth or value investors2025 Trade Ideas & AI Forecasted Entry and Exit Points - خودرو بانک
Highs Report: Is Tenaya Therapeutics Inc part of any ETF2025 Earnings Surprises & Free Reliable Trade Execution Plans - خودرو بانک
Technical Analysis: Does Tenaya Therapeutics Inc stock have upside surprise potentialJuly 2025 Big Picture & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Macro Review: Is Tenaya Therapeutics Inc in a consolidation phase2025 EndofYear Setup & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Risks Report: Is Tenaya Therapeutics Inc in a long term uptrend2025 Price Momentum & Free Long-Term Investment Growth Plans - خودرو بانک
Published on: 2025-09-16 10:56:48 - khodrobank.com
Sell Signal: Is Tenaya Therapeutics Inc. stock forming a cup and handle2025 Sector Review & Growth Focused Investment Plans - خودرو بانک
Aug Wrap: Can Tenaya Therapeutics Inc generate free cash flowJuly 2025 Setups & High Accuracy Swing Trade Signals - خودرو بانک
Chipmakers Recap: Is Tenaya Therapeutics Inc. stock influenced by commodity pricesEarnings Overview Summary & Low Risk Entry Point Tips - خودرو بانک
How to use a screener to detect Tenaya Therapeutics Inc. breakoutsPortfolio Value Report & Free Accurate Trade Setup Notifications - newser.com
Tenaya’s Gene Therapy Bets Big On Heart Disease Breakthroughs - Finimize
Custom watchlist performance reports with Tenaya Therapeutics Inc.July 2025 Trends & Long-Term Capital Growth Strategies - newser.com
What MACD signals say about Tenaya Therapeutics Inc.Weekly Volume Report & Free AI Powered Buy and Sell Recommendations - newser.com
226,202 Shares in Tenaya Therapeutics, Inc. $TNYA Bought by Nuveen LLC - MarketBeat
Top 4 Biotech Stocks Set For A Breakout: Momentum Scores SurgeInflaRx (NASDAQ:IFRX), Alector (NASDAQ:ALEC) - Benzinga
Tenaya Therapeutics (NASDAQ:TNYA) Given Buy Rating at HC Wainwright - MarketBeat
Short interest data insights for Tenaya Therapeutics Inc.Earnings Trend Report & Advanced Swing Trade Entry Alerts - Newser
Why Tenaya Therapeutics Inc. is moving todayPortfolio Gains Report & Verified Stock Trade Ideas - Newser
Does Tenaya Therapeutics Inc. stock have upside surprise potentialRate Cut & AI Enhanced Market Trend Forecasts - خودرو بانک
Can Tenaya Therapeutics Inc. reach all time highs this yearWeekly Volume Report & Verified Momentum Stock Watchlist - خودرو بانک
What’s next for Tenaya Therapeutics Inc. stock price2025 Key Lessons & Long-Term Capital Growth Strategies - Newser
Can Tenaya Therapeutics Inc. deliver consistent EPS growth2025 Breakouts & Breakdowns & Smart Investment Allocation Tips - خودرو بانک
Published on: 2025-09-05 14:07:00 - Newser
Applying big data sentiment scoring on Tenaya Therapeutics Inc.2025 Sector Review & Low Risk High Reward Ideas - Newser
What analysts say about Tenaya Therapeutics Inc. stock outlookQuarterly Portfolio Summary & Community Verified Watchlist Alerts - Newser
Regression analysis insights on Tenaya Therapeutics Inc. performanceJuly 2025 News Drivers & AI Based Buy/Sell Signal Reports - Newser
What’s the recovery path for long term holders of Tenaya Therapeutics Inc.Quarterly Risk Review & Weekly Market Pulse Alerts - Newser
Long term hold vs stop loss in Tenaya Therapeutics Inc.July 2025 Closing Moves & Technical Analysis for Trade Confirmation - Newser
Using AI based signals to follow Tenaya Therapeutics Inc.2025 Market Trends & Safe Swing Trade Setups - Newser
Will Tenaya Therapeutics Inc. rebound enough to break evenJuly 2025 Sector Moves & Growth Focused Entry Reports - Newser
Is Tenaya Therapeutics Inc. a defensive stock2025 Year in Review & Fast Exit/Entry Strategy Plans - خودرو بانک
Will Tenaya Therapeutics Inc. see short term momentumJuly 2025 Update & Safe Entry Point Alerts - Newser
Earnings visualization tools for Tenaya Therapeutics Inc.Trade Exit Summary & Short-Term High Return Ideas - Newser
Risk Check: Is Tenaya Therapeutics Inc. a defensive stock2025 Volume Leaders & Community Trade Idea Sharing Platform - خودرو بانک
Is a relief rally coming for Tenaya Therapeutics Inc. holdersWeekly Stock Recap & Weekly High Return Forecasts - Newser
Historical volatility pattern of Tenaya Therapeutics Inc. visualizedJuly 2025 Fed Impact & Consistent Profit Trading Strategies - Newser
Tenaya Therapeutics shares rise 6.94% intraday after CEO to participate in Morgan Stanley conference. - AInvest
Signal strength of Tenaya Therapeutics Inc. stock in tech scanners2025 Momentum Check & Expert Curated Trade Setup Alerts - Newser
Is Tenaya Therapeutics Inc. forming higher highs and higher lowsJuly 2025 Rallies & Stock Portfolio Risk Management - خودرو بانک
Tenaya Therapeutics Inc Stock (TNYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tenaya Therapeutics Inc Stock (TNYA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Tingley Whittemore | Chief Medical Officer |
Aug 18 '25 |
Sale |
1.25 |
5,053 |
6,331 |
172,803 |
| Ali Faraz | Chief Executive Officer |
Aug 18 '25 |
Sale |
1.25 |
14,533 |
18,210 |
302,792 |
1.30%
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):